[1] |
LIU Lijing, QIAN Hong, MENG Qingxin, ZHANG Xiang, HE Bin, HE Jianbin, WEI Yingmin.
Sinomenine inhibits oxidative stress and pulmonary fibrosis by activating the Keap1/Nrf2 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 979-987.
|
[2] |
WANG Jie, LI Long, CHEN Feng, LIU Shengfei.
Research progress of nuclear factor erythroid 2-related factor 2 in pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1067-1072.
|
[3] |
LI Yating, YUE Hongmei, LIU Miaomiao, XU Jinhui, WU Xingdong, ZHU Haobin.
The possibility of phosphodiesterase 4 inhibitors as drug therapy for idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 818-823.
|
[4] |
WANG Donghui, JIANG Suwen, HU Airong, ZHU Bo, HE Zheyun, ZHANG Lukan, WANG Jialan, FAN Ying, LIN Ken .
Mulberry exerts antioxidant stress effect in rats with nonalcoholic fatty liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 609-616.
|
[5] |
WEI Zhenzhen, SUI Hua, JIANG Yulang, SUN Mingyu, YAN Huaru, WANG Ziyuan.
Research on the molecular mechanism of Zuo Jin Wan combined with cetuximab inducing ferroptosis in KRAS mutant colorectal cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 130-137.
|
[6] |
BAI Jia, YANG Hong, LI Lingling, ZHANG Yangyang, YANG Ying, LV Haihong.
Study on the effect of vitamin D on diabetic neuropathy through mitochondrial/autophagy pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 214-219.
|
[7] |
ZHU Haobin, YUE Hongmei, WU Xingdong, LIU Miaomiao, LI Yating, XU Jinhui.
Research progress on the role of the Nrf2 signaling pathway in the complications associated with obstructive sleep apnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1283-1291.
|
[8] |
YANG Zhian, ZHAO Yan, HE Yao, LIU Weiying, YU Qin.
Pyroptosis mediated renal injury caused by chronic intermittent hypoxia and the intervention effect of edaravone in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 10-18.
|
[9] |
ZHANG Jingyu, WANG Yihan, LI Jun, JIN Ping, SHEN Xiping, WANG Yingbin, LIU Jieting.
Involvement of autophagy in iron ion regulation promotes ferroptosis in cells undergoing intestinal ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 36-41.
|
[10] |
HUA Haiyan, YAN Jie, QIN Yufen.
Experimental study of schisandrin B attenuates acute myocardial ischemia injury in rats by inhibiting cardiomyocyte apoptosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 848-856.
|
[11] |
WANG Jinhuo, GAO Xinyue, GUO Jianrong.
Effect of COX-2 inhibitors on postoperative delirium in elderly patients undergoing orthopedic surgery and its possible mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 863-869.
|
[12] |
DU Jie, ZHAO Tingting, WANG Dalong, CHEN Xiaodong, LIU Kexin, WU Jingjing.
Role and research progress of CYP46A1 in neurodegenerative diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 925-935.
|
[13] |
YU Weidi, SONG Zhenshun.
Bone marrow-derived mesenchymal stem cells ameliorate severe acute pancreatitis-induced lung injury in rats via suppression of ferroptosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 721-728.
|
[14] |
LI Xueheng, LI Long.
Research progress on the relationship between melatonin and idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 715-720.
|
[15] |
WANG Xinli, XU Xiaqing, FANG Hanbing, GUO Yuzhong.
Study of TPA on enhancing the anti-tumor effects of cisplatin and reducing its renal toxicity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 535-543.
|